-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on ArcBest, Lowers Price Target to $64

Benzinga·04/30/2025 14:19:05
Listen to the news
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $100 to $64.